Krishna Institute of Medical Sciences Ltd
Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The company offers multidisciplinary healthcare services with primary, secondary, and tertiary care across 2-3 tier cities and an additional quaternary healthcare facility in tier-1 cities.
- Market Cap ₹ 26,953 Cr.
- Current Price ₹ 674
- High / Low ₹ 708 / 404
- Stock P/E 71.5
- Book Value ₹ 53.4
- Dividend Yield 0.00 %
- ROCE 15.1 %
- ROE 19.0 %
- Face Value ₹ 2.00
Pros
Cons
- Stock is trading at 12.6 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
512 | 567 | 664 | 918 | 1,123 | 1,330 | 1,651 | 2,198 | 2,498 | 3,035 | |
403 | 450 | 593 | 833 | 872 | 953 | 1,126 | 1,587 | 1,850 | 2,252 | |
Operating Profit | 109 | 118 | 71 | 85 | 251 | 377 | 524 | 611 | 648 | 783 |
OPM % | 21% | 21% | 11% | 9% | 22% | 28% | 32% | 28% | 26% | 26% |
5 | 3 | 37 | 6 | 5 | 9 | 27 | 41 | 13 | 43 | |
Interest | 37 | 32 | 88 | 49 | 44 | 37 | 22 | 37 | 55 | 90 |
Depreciation | 36 | 35 | 40 | 56 | 71 | 70 | 73 | 129 | 147 | 177 |
Profit before tax | 41 | 53 | -20 | -15 | 141 | 279 | 457 | 485 | 460 | 558 |
Tax % | 32% | 37% | 126% | 223% | 18% | 26% | 25% | 25% | 27% | 26% |
28 | 33 | -46 | -49 | 115 | 205 | 344 | 366 | 336 | 415 | |
EPS in Rs | 0.76 | 0.91 | -1.32 | -1.28 | 3.20 | 5.19 | 8.32 | 8.41 | 7.75 | 9.61 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 22% |
3 Years: | 23% |
TTM: | 21% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 27% |
3 Years: | 4% |
TTM: | 22% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 41% |
1 Year: | 58% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 22% |
3 Years: | 19% |
Last Year: | 19% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 70 | 72 | 50 | 74 | 74 | 78 | 80 | 80 | 80 | 80 |
Reserves | 193 | 255 | -209 | 466 | 524 | 786 | 1,307 | 1,590 | 1,748 | 2,058 |
256 | 280 | 753 | 336 | 369 | 316 | 257 | 678 | 1,355 | 2,557 | |
146 | 167 | 359 | 237 | 228 | 253 | 260 | 553 | 636 | 1,042 | |
Total Liabilities | 665 | 774 | 954 | 1,114 | 1,194 | 1,433 | 1,904 | 2,901 | 3,820 | 5,736 |
515 | 518 | 755 | 863 | 916 | 931 | 1,005 | 1,766 | 2,434 | 3,348 | |
CWIP | 2 | 64 | 0 | 0 | 2 | 9 | 21 | 477 | 600 | 1,214 |
Investments | 11 | 14 | 0 | 0 | 0 | 0 | 332 | 68 | 157 | 99 |
137 | 177 | 199 | 250 | 276 | 493 | 546 | 590 | 629 | 1,075 | |
Total Assets | 665 | 774 | 954 | 1,114 | 1,194 | 1,433 | 1,904 | 2,901 | 3,820 | 5,736 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
95 | 82 | 106 | 134 | 202 | 356 | 324 | 432 | 521 | 582 | |
-41 | -100 | -64 | -110 | -125 | -354 | -412 | -416 | -753 | -1,116 | |
-65 | 24 | -39 | -27 | -44 | 10 | 61 | 20 | 217 | 543 | |
Net Cash Flow | -11 | 5 | 3 | -3 | 32 | 12 | -26 | 36 | -15 | 9 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 47 | 59 | 59 | 49 | 43 | 30 | 28 | 42 | 43 | 48 |
Inventory Days | 36 | 43 | 46 | 47 | 44 | 30 | 37 | 37 | ||
Days Payable | 194 | 207 | 215 | 181 | 177 | 167 | 133 | 157 | ||
Cash Conversion Cycle | -111 | -105 | -110 | -85 | -91 | -106 | -67 | 42 | 43 | -72 |
Working Capital Days | 11 | 26 | -315 | -7 | -10 | -6 | 4 | 15 | 13 | 6 |
ROCE % | 15% | 11% | 5% | 20% | 29% | 34% | 24% | 17% | 15% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
23 Jun - Scheduled analyst meeting with Moneylicious Securities on June 26, 2025, in Hyderabad.
-
Closure of Trading Window
23 Jun - Trading window closed from July 1, 2025, till 48 hours post Q1 results announcement.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
21 Jun - Scheduled analyst meeting with B&K Securities on June 25, 2025, in Hyderabad.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 20 Jun
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
18 Jun - Scheduled virtual analyst meeting with KKA Family Office on June 24, 2025.
Annual reports
Concalls
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023TranscriptPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
May 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Oct 2021TranscriptNotesPPT
-
Aug 2021Transcript PPT
Regional Leadership
KIMS Hospitals is one of the largest corporate healthcare groups in Telangana and AP, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost. The Group offers healthcare services in specialties and super specialties across more than 40 fields. [1]